| Year |
Citation |
Score |
| 2020 |
Rios-Romenets S, Lopera F, Sink KM, Hu N, Lian Q, Guthrie H, Smith J, Cho W, Mackey H, Langbaum JB, Thomas RG, Giraldo-Chica M, Tobon C, Acosta-Baena N, Muñoz C, ... ... Malek-Ahmadi MH, et al. Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal-Dominant Alzheimer's Disease Colombia Trial. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32418361 DOI: 10.1002/Alz.12109 |
0.383 |
|
| 2020 |
He B, Perez SE, Lee SH, Ginsberg SD, Malek-Ahmadi M, Mufson EJ. Expression profiling of precuneus layer III cathepsin D-immunopositive pyramidal neurons in mild cognitive impairment and Alzheimer's disease: Evidence for neuronal signaling vulnerability. The Journal of Comparative Neurology. PMID 32323319 DOI: 10.1002/cne.24929 |
0.586 |
|
| 2020 |
Moreno-Rodriguez M, Perez SE, Nadeem M, Malek-Ahmadi M, Mufson EJ. Frontal cortex chitinase and pentraxin neuroinflammatory alterations during the progression of Alzheimer's disease. Journal of Neuroinflammation. 17: 58. PMID 32066474 DOI: 10.1186/S12974-020-1723-X |
0.629 |
|
| 2020 |
Malek-Ahmadi M, Perez SE, Chen K, Mufson EJ. Braak Stage, Cerebral Amyloid Angiopathy, and Cognitive Decline in Early Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 31985469 DOI: 10.3233/Jad-191151 |
0.693 |
|
| 2020 |
Malek-Ahmadi M, Kahlon V, Adler CH, Obradov A, Thind K, Shill HA, Sue LI, Caviness JN, Jacobson S, Sabbagh MN. Prevalence of Hippocampal Sclerosis in a Clinicopathologically Characterized Cohort. Clinical and Experimental Medical Sciences. 1: 317-327. PMID 25324686 DOI: 10.12988/CEMS.2013.13026 |
0.361 |
|
| 2019 |
Ginsberg SD, Malek-Ahmadi MH, Alldred MJ, Chen Y, Chen K, Chao MV, Counts SE, Mufson EJ. Brain-derived neurotrophic factor (BDNF) and TrkB hippocampal gene expression are putative predictors of neuritic plaque and neurofibrillary tangle pathology. Neurobiology of Disease. 104540. PMID 31349032 DOI: 10.1016/J.Nbd.2019.104540 |
0.527 |
|
| 2019 |
Malek-Ahmadi M, Beach TG, Zamrini E, Adler CH, Sabbagh MN, Shill HA, Jacobson SA, Belden CM, Caselli RJ, Woodruff BK, Rapscak SZ, Ahern GL, Shi J, Caviness JN, Driver-Dunckley E, et al. Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease. Plos One. 14: e0217566. PMID 31237877 DOI: 10.1371/Journal.Pone.0217566 |
0.566 |
|
| 2019 |
Perez SE, Miguel JC, He B, Malek-Ahmadi M, Abrahamson EE, Ikonomovic MD, Lott I, Doran E, Alldred MJ, Ginsberg SD, Mufson EJ. Frontal cortex and striatal cellular and molecular pathobiology in individuals with Down syndrome with and without dementia. Acta Neuropathologica. PMID 30734106 DOI: 10.1007/S00401-019-01965-6 |
0.607 |
|
| 2019 |
Stipho F, Malek-Ahmadi M, O'Connor K, Schofield S, Zamrini E. P4-611: DOMAIN-SPECIFIC SUBJECTIVE MEMORY COMPLAINTS ARE ASSOCIATED WITH MONTREAL COGNITIVE ASSESSMENT PERFORMANCE IN COGNITIVELY UNIMPAIRED OLDER ADULTS Alzheimer's & Dementia. 15: P1558-P1559. DOI: 10.1016/J.Jalz.2019.08.159 |
0.449 |
|
| 2019 |
Quiroz YT, Tariot PN, Sink K, Clayton D, Langbaum JB, Thomas RG, Giraldo M, Tobon C, Acosta-Baena N, Luna E, Londono M, Ospina P, Tirado V, Alvarez S, Chen K, ... ... Malek-Ahmadi M, et al. F4-04-04: Association Between Cerebral Amyloidosis And Worse Cognitive Performance In Preclinical Autosomal Dominant Alzheimer'S Disease: Baseline Findings From The Api Colombia Autosomal Dominant Ad Trial Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4728 |
0.556 |
|
| 2019 |
Su Y, Rios-Romenets S, Tariot PN, Sink K, Clayton D, Hu N, Guthrie H, Smith J, Cho W, Langbaum JB, Thomas RG, Giraldo M, Tobon C, Acosta-Baena N, Navarro A, ... ... Malek-Ahmadi M, et al. F4-04-03: Relationships Between Baseline Brain Imaging Biomarker Measurements And Age In The Api Autosomal Dominant Alzheimer'S Disease Colombia Trial Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4727 |
0.372 |
|
| 2019 |
Acosta-Baena N, Rios-Romenets S, Muñoz C, Bocanegra Y, Henao E, Giraldo M, Tobon C, Sink K, Hu N, Guthrie H, Smith J, Cho W, Langbaum JB, Thomas RG, Chen K, ... ... Malek-Ahmadi M, et al. F4-04-02: Age-Related Changes In Baseline Cognitive Measures In Unimpaired Psen1 E280A Mutation Carriers And Non-Carriers In The Api Autosomal Dominant Alzheimer'S Disease Colombia Trial Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4726 |
0.461 |
|
| 2019 |
Tariot PN, Lopera F, Sink K, Hu N, Guthrie H, Smith J, Cho W, Langbaum JB, Thomas RG, Giraldo M, Tobon C, Acosta-Baena N, Munoz C, Ospina P, Torado V, ... ... Malek-Ahmadi M, et al. F4-04-01: Trial Design, Data Sharing Risk Mitigation, And Baseline Clinical And Cognitive Data From The Api Autosomal Dominant Alzheimer'S Disease Colombia Trial Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4725 |
0.419 |
|
| 2019 |
Malek-Ahmadi M, Atri A, Belden C, Powell J, Davis K, O'Connor K, Schofield S, Zamrini E. P4-374: DEPRESSIVE AND ANXIETY SYMPTOM VARIABILITY ATTENUATES MEMORY AND EXECUTIVE FUNCTION MEASURE DECLINE ESTIMATES IN COGNITIVELY UNIMPAIRED OLDER ADULTS Alzheimer's & Dementia. 15: P1443-P1443. DOI: 10.1016/J.Jalz.2019.06.4045 |
0.351 |
|
| 2019 |
Malek-Ahmadi M, Luo J, Methuku V, Devadas V, Goradia DD, Su Y, Reiman EM. P3-334: IMPACT OF CEREBRAL ISCHEMIA SCORES, FIBRILLAR AMYLOID-B BURDEN AND AGE ON WHITE MATTER HYPERINTENSITY VOLUMES IN COGNITIVELY UNIMPAIRED OLDER ADULT APOE4 CARRIERS AND NON-CARRIERS Alzheimer's & Dementia. 15: P1068-P1069. DOI: 10.1016/J.Jalz.2019.06.3366 |
0.429 |
|
| 2019 |
Malek-Ahmadi M, Belden C, Powell J, Zamrini E, Adler C, Sabbagh MN, Shill H, Jacobson S, Caselli RJ, Woodruff BK, Rapscak SZ, Ahern GL, Shi J, Caviness JN, Driver-Dunckley E, et al. P2-430: RELATIONSHIPS BETWEEN LONGITUDINAL RATES OF LEARNING AND MEMORY DECLINE AND DIFFERENT FORMS OF CEREBROVASCULAR PATHOLOGY IN COGNITIVELY UNIMPAIRED BRAIN DONORS Alzheimer's & Dementia. 15: P777-P777. DOI: 10.1016/J.Jalz.2019.06.2837 |
0.404 |
|
| 2019 |
Protas H, Pardilla-Delgado E, Lopera F, Johnson KA, Sperling RA, Artola A, Baena A, Bocanegra Y, Gatchel JR, Guzman-Velez E, Fuller J, Goradia DD, Thiyyagura P, VanGilder PS, Luo J, ... ... Malek-Ahmadi M, et al. Ic-P-058: Covarying Spatial Patterns Of Tau Deposition And Gray Matter Atrophy Unearthed By The Informed Multimodal Partial Least Squares (Mmpls) In Autosomal Dominant Alzheimer'S Disease: Findings From The Colbos Project Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2767 |
0.368 |
|
| 2019 |
Malek-Ahmadi M, Su Y, Devadas V, Henslin BR, Locke DE, Woodruff BK, Dueck AC, Caselli RJ, Reiman EM. P1-480: APOE-DEPENDENT VERBAL LEARNING EFFECTS IN COGNITIVELY UNIMPAIRED OLDER ADULTS Alzheimer's & Dementia. 15: P453-P453. DOI: 10.1016/J.Jalz.2019.06.1085 |
0.389 |
|
| 2019 |
Protas H, Goradia DD, Ghisays V, Luo J, VanGilder PS, Thiyyagura P, Malek-Ahmadi M, Lee W, Chen Y, Devadas V, Bauer R, Landau SM, Weiner MW, Jagust WJ, Chen K, et al. Ic-P-173: Individual-Based Network Analysis: A Novel Approach To Investigate The Pathological Spread Of Phf Tau Using Graph Theory In Clinical And Preclinical Stages Of Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.1023 |
0.375 |
|
| 2018 |
Malek-Ahmadi M, Chen K, Perez ES, Mufson JE. Cerebral Amyloid Angiopathy and Neuritic Plaque Pathology Correlate with Cognitive Decline in Elderly Non-Demented Individuals. Journal of Alzheimer's Disease : Jad. PMID 30594928 DOI: 10.3233/Jad-180765 |
0.603 |
|
| 2018 |
Mahady L, Nadeem M, Malek-Ahmadi M, Chen K, Perez SE, Mufson EJ. HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease. Neuropathology and Applied Neurobiology. PMID 30252960 DOI: 10.1111/nan.12518 |
0.603 |
|
| 2018 |
Malek-Ahmadi M, Chen K, Perez SE, He A, Mufson EJ. Cognitive composite score association with Alzheimer's disease plaque and tangle pathology. Alzheimer's Research & Therapy. 10: 90. PMID 30205840 DOI: 10.1186/S13195-018-0401-Z |
0.691 |
|
| 2018 |
Mahady L, Nadeem M, Malek-Ahmadi M, Chen K, Perez SE, Mufson EJ. Frontal Cortex Epigenetic Dysregulation During the Progression of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 62: 115-131. PMID 29439356 DOI: 10.3233/Jad-171032 |
0.686 |
|
| 2017 |
Malek-Ahmadi M, Lu S, Chan Y, Perez SE, Chen K, Mufson EJ. Static and Dynamic Cognitive Reserve Proxy Measures: Interactions with Alzheimer's Disease Neuropathology and Cognition. Journal of Alzheimer's Disease & Parkinsonism. 7. PMID 29423338 DOI: 10.4172/2161-0460.1000390 |
0.64 |
|
| 2017 |
Malek-Ahmadi M, O'Connor K, Schofield S, Coon DW, Zamrini E. Trajectory and variability characterization of the Montreal cognitive assessment in older adults. Aging Clinical and Experimental Research. 30: 993-998. PMID 29188578 DOI: 10.1007/S40520-017-0865-X |
0.455 |
|
| 2017 |
Ginsberg SD, Malek-Ahmadi MH, Alldred MJ, Che S, Elarova I, Chen Y, Jeanneteau F, Kranz TM, Chao MV, Counts SE, Mufson EJ. Selective decline of neurotrophin and neurotrophin receptor genes within CA1 pyramidal neurons and hippocampus proper: Correlation with cognitive performance and neuropathology in mild cognitive impairment and Alzheimer's disease. Hippocampus. PMID 28888073 DOI: 10.1002/Hipo.22802 |
0.626 |
|
| 2017 |
Perez SE, Nadeem M, Malek-Ahmadi MH, He B, Mufson EJ. Frontal Cortex and Hippocampal γ-Secretase Activating Protein Levels in Prodromal Alzheimer Disease. Neuro-Degenerative Diseases. 17: 235-241. PMID 28743126 DOI: 10.1159/000477937 |
0.522 |
|
| 2017 |
Malek-Ahmadi M, Kora MK, O'Connor K, Schofield S, Coon D, Nieri W. Sleep duration and cognitive impairment in older adults: response. Aging Clinical and Experimental Research. 29: 819-820. PMID 28730544 DOI: 10.1007/S40520-017-0798-4 |
0.36 |
|
| 2017 |
Malek-Ahmadi M, Lu S, Chan Y, Perez SE, Chen K, Mufson EJ. Cognitive Domain Dispersion Association with Alzheimer's Disease Pathology. Journal of Alzheimer's Disease : Jad. PMID 28453479 DOI: 10.3233/Jad-161233 |
0.697 |
|
| 2017 |
Perez SE, Nadeem M, He B, Miguel JC, Malek-Ahmadi MH, Chen K, Mufson EJ. Neocortical and hippocampal TREM2 protein levels during the progression of Alzheimer's disease. Neurobiology of Aging. PMID 28365005 DOI: 10.1016/j.neurobiolaging.2017.02.012 |
0.627 |
|
| 2017 |
Malek-Ahmadi M. Reversion From Mild Cognitive Impairment to Normal Cognition: A Meta-Analysis. Alzheimer Disease and Associated Disorders. 30: 324-330. PMID 26908276 DOI: 10.1097/Wad.0000000000000145 |
0.52 |
|
| 2017 |
Malek-Ahmadi M, Mufson EJ, Perez SE, Chen K. Statistical considerations for assessing cognition and neuropathology associations in preclinical Alzheimer's disease Biostatistics & Epidemiology. 1: 92-104. DOI: 10.1080/24709360.2017.1342186 |
0.64 |
|
| 2017 |
Malek-Ahmadi M, Lu S, Chan YY, Perez SE, Chen K, Mufson EJ. [P2-434]: INTELLECTUAL FUNCTION VERSUS YEARS OF EDUCATION AS COGNITIVE RESERVE PROXIES: INTERACTION WITH ALZHEIMER's DISEASE NEUROPATHOLOGY AND IMPACT ON EPISODIC MEMORY AND EXECUTIVE FUNCTION Alzheimer's & Dementia. 13: P802-P802. DOI: 10.1016/J.Jalz.2017.06.1090 |
0.613 |
|
| 2016 |
Malek-Ahmadi M, Perez SE, Chen K, Mufson EJ. Neuritic and Diffuse Plaque Associations with Memory in Non-Cognitively Impaired Elderly. Journal of Alzheimer's Disease : Jad. 53: 1641-1652. PMID 27540968 DOI: 10.3233/Jad-160365 |
0.686 |
|
| 2016 |
Mufson EJ, Malek-Ahmadi M, Snyder N, Ausdemore J, Chen K, Perez SE. Braak stage and trajectory of cognitive decline in noncognitively impaired elders. Neurobiology of Aging. 43: 101-10. PMID 27255819 DOI: 10.1016/J.Neurobiolaging.2016.03.003 |
0.672 |
|
| 2016 |
Mufson EJ, Ikonomovic MD, Counts SE, Perez SE, Malek-Ahmadi M, Scheff SW, Ginsberg SD. Molecular and Cellular Pathophysiology of Preclinical Alzheimer's Disease. Behavioural Brain Research. PMID 27185734 DOI: 10.1016/J.Bbr.2016.05.030 |
0.704 |
|
| 2016 |
Birch K, Ten Hope M, Malek-Ahmadi M, O'Connor K, Schofield S, Coon D, Nieri W. Cognitive Function as a Mediator in the Relationship Between Physical Activity and Depression Status in Older Adults. Journal of Aging and Physical Activity. PMID 27051070 DOI: 10.1123/Japa.2015-0029 |
0.363 |
|
| 2016 |
Mufson EJ, Malek-Ahmadi M, Perez SE, Chen K. Braak staging, plaque pathology, and APOE status in elderly persons without cognitive impairment. Neurobiology of Aging. 37: 147-53. PMID 26686670 DOI: 10.1016/J.Neurobiolaging.2015.10.012 |
0.696 |
|
| 2016 |
Malek-Ahmadi M, Kora K, O'Connor K, Schofield S, Coon D, Nieri W. Longer self-reported sleep duration is associated with decreased performance on the montreal cognitive assessment in older adults. Aging Clinical and Experimental Research. 28: 333-7. PMID 26063636 DOI: 10.1007/S40520-015-0388-2 |
0.361 |
|
| 2016 |
Dugger BN, Malek-Ahmadi M, Monsell SE, Kukull WA, Woodruff BK, Reiman EM, Beach TG, Wilson J. A Cross-Sectional Analysis of Late-Life Cardiovascular Factors and Their Relation to Clinically Defined Neurodegenerative Diseases Alzheimer Disease and Associated Disorders. DOI: 10.1097/Wad.0000000000000138 |
0.478 |
|
| 2016 |
Mufson EJ, Malek-Ahmadi M, Snyder N, Ausdemore J, Chen K, Perez SE. Braak stage and trajectory of cognitive decline in noncognitively impaired elders Neurobiology of Aging. 43: 101-110. DOI: 10.1016/j.neurobiolaging.2016.03.003 |
0.639 |
|
| 2015 |
Malek-Ahmadi M, Chen K, Davis K, Belden CM, Powell J, Jacobson SA, Sabbagh MN. Sensitivity to change and prediction of global change for the Alzheimer's Questionnaire. Alzheimer's Research & Therapy. 7: 1. PMID 26584966 DOI: 10.1186/S13195-014-0092-Z |
0.547 |
|
| 2015 |
O'Connor K, Coon DW, Malek-Ahmadi M, Dugger BN, Schofield S, Nieri W. Description and cohort characterization of the Longevity Study: learning from our elders. Aging Clinical and Experimental Research. PMID 26572156 DOI: 10.1007/S40520-015-0488-Z |
0.341 |
|
| 2015 |
Dugger BN, Davis K, Malek-Ahmadi M, Hentz JG, Sandhu S, Beach TG, Adler CH, Caselli RJ, Johnson TA, Serrano GE, Shill HA, Belden C, Driver-Dunckley E, Caviness JN, Sue LI, et al. Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment. Bmc Neurology. 15: 146. PMID 26289075 DOI: 10.1186/S12883-015-0403-4 |
0.616 |
|
| 2015 |
Malek-Ahmadi M, Powell JJ, Belden CM, O'Connor K, Evans L, Coon DW, Nieri W. Age- and education-adjusted normative data for the Montreal Cognitive Assessment (MoCA) in older adults age 70-99. Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition. 1-7. PMID 25942388 DOI: 10.1080/13825585.2015.1041449 |
0.342 |
|
| 2015 |
Sabbagh MN, Chen K, Rogers J, Fleisher AS, Liebsack C, Bandy D, Belden C, Protas H, Thiyyagura P, Liu X, Roontiva A, Luo J, Jacobson S, Malek-Ahmadi M, Powell J, et al. Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25849033 DOI: 10.1016/J.Jalz.2015.01.006 |
0.351 |
|
| 2015 |
Budolfson K, Malek-Ahmadi M, Belden CM, Powell J, Davis K, Jacobson S, Sabbagh MN. Neuropsychological Correlates of the Alzheimer's Questionnaire. Journal of Alzheimer's Disease : Jad. PMID 25737045 DOI: 10.3233/Jad-142388 |
0.538 |
|
| 2015 |
Beach TG, Adler CH, Sue LI, Serrano G, Shill HA, Walker DG, Lue L, Roher AE, Dugger BN, Maarouf C, Birdsill AC, Intorcia A, Saxon-Labelle M, Pullen J, Scroggins A, ... ... Malek-Ahmadi M, et al. Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program. Neuropathology : Official Journal of the Japanese Society of Neuropathology. 35: 354-89. PMID 25619230 DOI: 10.1111/Neup.12189 |
0.344 |
|
| 2015 |
Belden CM, Kahlon V, Malek-Ahmadi M, Tsai A, Sabbagh MN. Clinical characterization of mild cognitive impairment as a prodrome to dementia with Lewy bodies. American Journal of Alzheimer's Disease and Other Dementias. 30: 173-7. PMID 25013117 DOI: 10.1177/1533317514542642 |
0.497 |
|
| 2015 |
Dugger BN, Davis K, Malek-Ahmadi M, Hentz JG, Sandhu S, Beach TG, Adler CH, Caselli RJ, Johnson TA, Serrano GE, Shill HA, Belden C, Driver-Dunckley E, Caviness JN, Sue LI, et al. Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment Bmc Neurology. 15. DOI: 10.1186/s12883-015-0403-4 |
0.406 |
|
| 2014 |
Tsai A, Malek-Ahmadi M, Kahlon V, Sabbagh MN. Differences in Cerebrospinal Fluid Biomarkers between Clinically Diagnosed Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease. Journal of Alzheimer's Disease & Parkinsonism. 4. PMID 25937995 DOI: 10.4172/2161-0460.1000150 |
0.462 |
|
| 2014 |
Malek-Ahmadi M, Davis K, Belden CM, Sabbagh MN. Comparative analysis of the Alzheimer questionnaire (AQ) with the CDR sum of boxes, MoCA, and MMSE. Alzheimer Disease and Associated Disorders. 28: 296-8. PMID 23138174 DOI: 10.1097/Wad.0B013E3182769731 |
0.543 |
|
| 2013 |
Malek-Ahmadi M, Patel A, Sabbagh MN. KIF6 719Arg Carrier Status Association with Homocysteine and C-Reactive Protein in Amnestic Mild Cognitive Impairment and Alzheimer's Disease Patients. International Journal of Alzheimer's Disease. 2013: 242303. PMID 24455405 DOI: 10.1155/2013/242303 |
0.538 |
|
| 2013 |
Sabbagh MN, Malek-Ahmadi M, Dugger BN, Lee K, Sue LI, Serrano G, Walker DG, Davis K, Jacobson SA, Beach TG. The influence of Apolipoprotein E genotype on regional pathology in Alzheimer's disease. Bmc Neurology. 13: 44. PMID 23663404 DOI: 10.1186/1471-2377-13-44 |
0.504 |
|
| 2013 |
Malek-Ahmadi M, Beach T, Obradov A, Sue L, Belden C, Davis K, Walker DG, Lue L, Adem A, Sabbagh MN. Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status. Current Alzheimer Research. 10: 654-9. PMID 23627755 DOI: 10.2174/15672050113109990006 |
0.496 |
|
| 2013 |
Maarouf CL, Beach TG, Adler CH, Malek-Ahmadi M, Kokjohn TA, Dugger BN, Walker DG, Shill HA, Jacobson SA, Sabbagh MN, Roher AE. Quantitative appraisal of ventricular cerebrospinal fluid biomarkers in neuropathologically diagnosed Parkinson's disease cases lacking Alzheimer's disease pathology. Biomarker Insights. 8: 19-28. PMID 23533154 DOI: 10.4137/Bmi.S11422 |
0.423 |
|
| 2013 |
Kokjohn TA, Maarouf CL, Daugs ID, Hunter JM, Whiteside CM, Malek-Ahmadi M, Rodriguez E, Kalback W, Jacobson SA, Sabbagh MN, Beach TG, Roher AE. Neurochemical profile of dementia pugilistica. Journal of Neurotrauma. 30: 981-97. PMID 23268705 DOI: 10.1089/Neu.2012.2699 |
0.454 |
|
| 2013 |
Decourt B, Gonzales A, Beach TG, Malek-Ahmadi M, Walker A, Sue L, Walker DG, Sabbagh MN. BACE1 levels by APOE genotype in non-demented and Alzheimer's post-mortem brains. Current Alzheimer Research. 10: 309-15. PMID 23036023 DOI: 10.2174/1567205011310030010 |
0.48 |
|
| 2013 |
Sabbagh M, Malek-Ahmadi M, Levenson I, Sparks DL. KIF6 719Arg allele is associated with statin effects on cholesterol levels in amnestic mild cognitive impairment and Alzheimer's disease patients. Journal of Alzheimer's Disease : Jad. 33: 111-6. PMID 22914592 DOI: 10.3233/Jad-2012-121015 |
0.452 |
|
| 2013 |
Decourt B, Walker A, Gonzales A, Malek-Ahmadi M, Liesback C, Davis KJ, Belden CM, Jacobson SA, Sabbagh MN. Can platelet BACE1 levels be used as a biomarker for Alzheimer's disease? Proof-of-concept study. Platelets. 24: 235-8. PMID 22775589 DOI: 10.3109/09537104.2012.688899 |
0.494 |
|
| 2013 |
Sabbagh MN, Malek-Ahmadi M, Belden CM. The use of informant-based questionnaires in differentiating mild cognitive impairment from normal aging. Expert Review of Neurotherapeutics. 12: 637-9. PMID 22650164 DOI: 10.1586/Ern.12.45 |
0.548 |
|
| 2013 |
Dugger B, Saxon-LaBelle M, Chiarolanza G, Hidalgo T, Malek-Ahmadi M, Wilson J, Roher A, Beach T. P2-223: Examination of body mass index, organ weights and diagnosed medical conditions in an autopsy series of nondemented individuals and individuals with Alzheimer's disease Alzheimer's & Dementia. 9: P438-P439. DOI: 10.1016/J.Jalz.2013.05.869 |
0.34 |
|
| 2013 |
Sabbagh M, Decourt B, Liebsack C, Sirrel S, Walker A, Gonzales A, Macias M, Jacobson S, Malek-Ahmadi M, Belden C. A phase II double-blind, placebo-controlled randomized trial of an escalating dose of thalidomide in the treatment of Alzheimer's disease: Baseline characteristics Alzheimers & Dementia. 9: 285. DOI: 10.1016/J.Jalz.2013.05.575 |
0.313 |
|
| 2013 |
Malek-Ahmadi M, Sabbagh M. P1-249: KIF6 719Arg carrier status association with homocysteine and C-reactive protein in mild cognitive impairment and Alzheimer's disease Alzheimer's & Dementia. 9: P243-P243. DOI: 10.1016/J.Jalz.2013.05.473 |
0.536 |
|
| 2012 |
Roher AE, Debbins JP, Malek-Ahmadi M, Chen K, Pipe JG, Maze S, Belden C, Maarouf CL, Thiyyagura P, Mo H, Hunter JM, Kokjohn TA, Walker DG, Kruchowsky JC, Belohlavek M, et al. Cerebral blood flow in Alzheimer's disease. Vascular Health and Risk Management. 8: 599-611. PMID 23109807 DOI: 10.2147/Vhrm.S34874 |
0.535 |
|
| 2012 |
Hunter JM, Kwan J, Malek-Ahmadi M, Maarouf CL, Kokjohn TA, Belden C, Sabbagh MN, Beach TG, Roher AE. Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer's disease. Plos One. 7: e36893. PMID 22615835 DOI: 10.1371/Journal.Pone.0036893 |
0.539 |
|
| 2012 |
Malek-Ahmadi M, Davis K, Belden C, Laizure B, Jacobson S, Yaari R, Singh U, Sabbagh MN. Validation and diagnostic accuracy of the Alzheimer's questionnaire. Age and Ageing. 41: 396-9. PMID 22367356 DOI: 10.1093/Ageing/Afs008 |
0.56 |
|
| 2012 |
Malek-Ahmadi M, Davis K, Belden CM, Jacobson S, Sabbagh MN. Informant-reported cognitive symptoms that predict amnestic mild cognitive impairment. Bmc Geriatrics. 12: 3. PMID 22304759 DOI: 10.1186/1471-2318-12-3 |
0.513 |
|
| 2012 |
Malek-Ahmadi M, Davis K, Belden C, Sabbagh M. P3-261: Concurrent validity of the Alzheimer's Questionnaire (AQ) Alzheimer's & Dementia. 8: P551-P551. DOI: 10.1016/J.Jalz.2012.05.1484 |
0.404 |
|
| 2012 |
Sabbagh M, Malek-Ahmadi M, Levenson I, Sparks L. P2-385: KIF6 719Arg allele predicts statin responsiveness in amnestic mild cognitive impairment and Alzheimer's disease patients Alzheimer's & Dementia. 8: P398-P398. DOI: 10.1016/J.Jalz.2012.05.1095 |
0.329 |
|
| 2011 |
Malek-Ahmadi M, Small BJ, Raj A. The diagnostic value of controlled oral word association test-FAS and category fluency in single-domain amnestic mild cognitive impairment. Dementia and Geriatric Cognitive Disorders. 32: 235-40. PMID 22156335 DOI: 10.1159/000334525 |
0.584 |
|
| 2011 |
Malek-Ahmadi M, Raj A, Small BJ. Semantic clustering as a neuropsychological predictor for amnestic-MCI. Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition. 18: 280-92. PMID 21347885 DOI: 10.1080/13825585.2010.540642 |
0.563 |
|
| 2011 |
Sabbagh M, Malek-Ahmadi M, Levenson I, Sparks L. P2-064: Can the KIF6 polymorphism predict statin responsiveness in prodromal and symptomatic Alzheimer's disease? Alzheimer's & Dementia. 7: S328-S328. DOI: 10.1016/J.Jalz.2011.05.954 |
0.389 |
|
| 2011 |
Obradov A, Obradov A, Malek-Ahmadi M, Beach T, Sue L, Belden C, Davis K, Sabbagh M. P4-024: How does diabetes affect plaque and tangle pathology in Alzheimer's Disease? Alzheimer's & Dementia. 7: S706-S706. DOI: 10.1016/J.Jalz.2011.05.2044 |
0.411 |
|
| 2010 |
Sabbagh MN, Malek-Ahmadi M, Kataria R, Belden CM, Connor DJ, Pearson C, Jacobson S, Davis K, Yaari R, Singh U. The Alzheimer's questionnaire: a proof of concept study for a new informant-based dementia assessment. Journal of Alzheimer's Disease : Jad. 22: 1015-21. PMID 20930293 DOI: 10.3233/Jad-2010-101185 |
0.534 |
|
| 2006 |
Malek-Ahmadi M, Chen K, Perez SE, Mufson EJ. O2-03-04: CEREBRAL AMYLOID ANGIOPATHY CORRELATES WITH COGNITIVE DECLINE IN PRECLINICAL AD Alzheimer's & Dementia. 14: P617-P617. DOI: 10.1016/J.Jalz.2018.06.2654 |
0.647 |
|
| Show low-probability matches. |